Serum urate predicts long-term risk of acute coronary events in women after a transient ischaemic attack and stroke

Silvia Koton, Sally C. Howard, Charles P. Warlow, Michael F G Murphy, Peter M. Rothwell

Research output: Contribution to journalArticle

Abstract

Background: Several studies have shown serum urate to be an independent risk factor for vascular disease, but others have not, although a stronger association in women than in men has been a consistent finding. Studies of stroke patients have shown possible associations between urate level and stroke severity, but there have been no large cohort studies of the effect of urate on the long-term risk of future vascular events in patients with a transient ischaemic attack (TIA) or stroke. We studied this relationship in 2 independent cohorts. Methods: Individual data on 15,483 patient-years of follow-up from the UK-TIA trial (13,182 patient-years) and the Oxford TIA study (2,301 patient-years) were analyzed. Hazard ratios (per unit increase of baseline urate in mg/dl) for the risks of stroke and acute coronary events (ACE) were obtained from Cox models stratified by study, with and without adjustment for potential confounders. Potential interactions between urate and baseline characteristics were also assessed. Results: Linear associations between urate and risk of ACE were found in both studies: pooled age- and sex-adjusted hazard ratio = 1.17, 95% CI 1.06-1.30, per unit increase of urate (p = 0.003). Sex, body mass index and previous myocardial infarction or angina were effect modifiers, but only the effect of sex remained after adjustment for other risk factors (p = 0.002), with a 5th:1st quintile hazard ratio of 4.23 (1.97-9.07, p <0.0001) in women and 1.09 (0.70-1.71, p = 0.69) in men. These findings were consistent across the 2 studies. No associations were found between urate level and either risk or severity of stroke. Conclusions: High urate levels were independent predictors of long-term risk of ACE in women who had a TIA or stroke, but not in men, in 2 independent studies. Urate levels could be useful in identifying women at high risk of coronary events in routine practice.

Original languageEnglish (US)
Pages (from-to)517-524
Number of pages8
JournalCerebrovascular Diseases
Volume26
Issue number5
DOIs
StatePublished - Nov 2008
Externally publishedYes

Fingerprint

Transient Ischemic Attack
Uric Acid
Stroke
Serum
Cohort Effect
Vascular Diseases
Proportional Hazards Models
Blood Vessels
Body Mass Index
Cohort Studies
Myocardial Infarction

Keywords

  • Acute coronary events
  • Serum uric acid
  • Stroke
  • Transient ischaemic attack
  • Urate

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology
  • Cardiology and Cardiovascular Medicine

Cite this

Serum urate predicts long-term risk of acute coronary events in women after a transient ischaemic attack and stroke. / Koton, Silvia; Howard, Sally C.; Warlow, Charles P.; Murphy, Michael F G; Rothwell, Peter M.

In: Cerebrovascular Diseases, Vol. 26, No. 5, 11.2008, p. 517-524.

Research output: Contribution to journalArticle

Koton, Silvia ; Howard, Sally C. ; Warlow, Charles P. ; Murphy, Michael F G ; Rothwell, Peter M. / Serum urate predicts long-term risk of acute coronary events in women after a transient ischaemic attack and stroke. In: Cerebrovascular Diseases. 2008 ; Vol. 26, No. 5. pp. 517-524.
@article{0d332b5ee5a3458fa426dea82b2d0cec,
title = "Serum urate predicts long-term risk of acute coronary events in women after a transient ischaemic attack and stroke",
abstract = "Background: Several studies have shown serum urate to be an independent risk factor for vascular disease, but others have not, although a stronger association in women than in men has been a consistent finding. Studies of stroke patients have shown possible associations between urate level and stroke severity, but there have been no large cohort studies of the effect of urate on the long-term risk of future vascular events in patients with a transient ischaemic attack (TIA) or stroke. We studied this relationship in 2 independent cohorts. Methods: Individual data on 15,483 patient-years of follow-up from the UK-TIA trial (13,182 patient-years) and the Oxford TIA study (2,301 patient-years) were analyzed. Hazard ratios (per unit increase of baseline urate in mg/dl) for the risks of stroke and acute coronary events (ACE) were obtained from Cox models stratified by study, with and without adjustment for potential confounders. Potential interactions between urate and baseline characteristics were also assessed. Results: Linear associations between urate and risk of ACE were found in both studies: pooled age- and sex-adjusted hazard ratio = 1.17, 95{\%} CI 1.06-1.30, per unit increase of urate (p = 0.003). Sex, body mass index and previous myocardial infarction or angina were effect modifiers, but only the effect of sex remained after adjustment for other risk factors (p = 0.002), with a 5th:1st quintile hazard ratio of 4.23 (1.97-9.07, p <0.0001) in women and 1.09 (0.70-1.71, p = 0.69) in men. These findings were consistent across the 2 studies. No associations were found between urate level and either risk or severity of stroke. Conclusions: High urate levels were independent predictors of long-term risk of ACE in women who had a TIA or stroke, but not in men, in 2 independent studies. Urate levels could be useful in identifying women at high risk of coronary events in routine practice.",
keywords = "Acute coronary events, Serum uric acid, Stroke, Transient ischaemic attack, Urate",
author = "Silvia Koton and Howard, {Sally C.} and Warlow, {Charles P.} and Murphy, {Michael F G} and Rothwell, {Peter M.}",
year = "2008",
month = "11",
doi = "10.1159/000155990",
language = "English (US)",
volume = "26",
pages = "517--524",
journal = "Cerebrovascular Diseases",
issn = "1015-9770",
publisher = "S. Karger AG",
number = "5",

}

TY - JOUR

T1 - Serum urate predicts long-term risk of acute coronary events in women after a transient ischaemic attack and stroke

AU - Koton, Silvia

AU - Howard, Sally C.

AU - Warlow, Charles P.

AU - Murphy, Michael F G

AU - Rothwell, Peter M.

PY - 2008/11

Y1 - 2008/11

N2 - Background: Several studies have shown serum urate to be an independent risk factor for vascular disease, but others have not, although a stronger association in women than in men has been a consistent finding. Studies of stroke patients have shown possible associations between urate level and stroke severity, but there have been no large cohort studies of the effect of urate on the long-term risk of future vascular events in patients with a transient ischaemic attack (TIA) or stroke. We studied this relationship in 2 independent cohorts. Methods: Individual data on 15,483 patient-years of follow-up from the UK-TIA trial (13,182 patient-years) and the Oxford TIA study (2,301 patient-years) were analyzed. Hazard ratios (per unit increase of baseline urate in mg/dl) for the risks of stroke and acute coronary events (ACE) were obtained from Cox models stratified by study, with and without adjustment for potential confounders. Potential interactions between urate and baseline characteristics were also assessed. Results: Linear associations between urate and risk of ACE were found in both studies: pooled age- and sex-adjusted hazard ratio = 1.17, 95% CI 1.06-1.30, per unit increase of urate (p = 0.003). Sex, body mass index and previous myocardial infarction or angina were effect modifiers, but only the effect of sex remained after adjustment for other risk factors (p = 0.002), with a 5th:1st quintile hazard ratio of 4.23 (1.97-9.07, p <0.0001) in women and 1.09 (0.70-1.71, p = 0.69) in men. These findings were consistent across the 2 studies. No associations were found between urate level and either risk or severity of stroke. Conclusions: High urate levels were independent predictors of long-term risk of ACE in women who had a TIA or stroke, but not in men, in 2 independent studies. Urate levels could be useful in identifying women at high risk of coronary events in routine practice.

AB - Background: Several studies have shown serum urate to be an independent risk factor for vascular disease, but others have not, although a stronger association in women than in men has been a consistent finding. Studies of stroke patients have shown possible associations between urate level and stroke severity, but there have been no large cohort studies of the effect of urate on the long-term risk of future vascular events in patients with a transient ischaemic attack (TIA) or stroke. We studied this relationship in 2 independent cohorts. Methods: Individual data on 15,483 patient-years of follow-up from the UK-TIA trial (13,182 patient-years) and the Oxford TIA study (2,301 patient-years) were analyzed. Hazard ratios (per unit increase of baseline urate in mg/dl) for the risks of stroke and acute coronary events (ACE) were obtained from Cox models stratified by study, with and without adjustment for potential confounders. Potential interactions between urate and baseline characteristics were also assessed. Results: Linear associations between urate and risk of ACE were found in both studies: pooled age- and sex-adjusted hazard ratio = 1.17, 95% CI 1.06-1.30, per unit increase of urate (p = 0.003). Sex, body mass index and previous myocardial infarction or angina were effect modifiers, but only the effect of sex remained after adjustment for other risk factors (p = 0.002), with a 5th:1st quintile hazard ratio of 4.23 (1.97-9.07, p <0.0001) in women and 1.09 (0.70-1.71, p = 0.69) in men. These findings were consistent across the 2 studies. No associations were found between urate level and either risk or severity of stroke. Conclusions: High urate levels were independent predictors of long-term risk of ACE in women who had a TIA or stroke, but not in men, in 2 independent studies. Urate levels could be useful in identifying women at high risk of coronary events in routine practice.

KW - Acute coronary events

KW - Serum uric acid

KW - Stroke

KW - Transient ischaemic attack

KW - Urate

UR - http://www.scopus.com/inward/record.url?scp=52049105903&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=52049105903&partnerID=8YFLogxK

U2 - 10.1159/000155990

DO - 10.1159/000155990

M3 - Article

C2 - 18810239

AN - SCOPUS:52049105903

VL - 26

SP - 517

EP - 524

JO - Cerebrovascular Diseases

JF - Cerebrovascular Diseases

SN - 1015-9770

IS - 5

ER -